New evidence elucidates the mystery of the genetic basis of Tourette syndrome (TS) that has puzzled medical researchers for over a century. This remarkable discovery linking genes, brain, mind and behaviour provides unparalleled insight into the biological basis of human behaviour. [ + ]

Researchers at Population Genetics Technologies (Cambridge, UK) have developed and validated an innovative technology - Reflex - for efficient targeted sequencing of long DNA regions in large numbers of genomic DNA samples. [ + ]

A research team from the UK’s National Physics Laboratory and the University of Edinburgh have invented a new way to zip and unzip DNA strands using electrochemistry. [ + ]

Research shows that fainting may be genetically determined, providing a better understanding of this common condition [ + ]

Novogen (ASX:NRT) non-executive director Josiah Austin has resigned to avoid having to fly from the US to Australia for monthly board meetings. [ + ]

Starpharma (ASX:SPL) has been granted three new US patents for its dendrimer drug delivery platform and will soon pick up a patent in China. [ + ]

A team of Australian engineers at the University of New South Wales (UNSW) has demonstrated a quantum bit based on the nucleus of a single atom in silicon, promising dramatic improvements for data processing in ultrapowerful quantum computers of the future. [ + ]

The Draft Report of the Pharmaceutical Patent Review is now open for comment. [ + ]

Toshiba Healthcare will this month start distributing Nanosonics’ (ASX:NAN) Trophon EPR ultrasound probe disinfection cabinets. [ + ]

A new web-based educational tool is engaging rheumatologists. [ + ]

Researchers are one step closer to capturing the dynamics of molecular movement at the atomic level. [ + ]

Dr Eric Rose, the cardiovascular surgeon who performed the first successful paediatric heart transplant, has joined Mesoblast’s board of directors. [ + ]

Winning images of a cell biology image competition lit up Times Square in New York in April. [ + ]

Phosphagenics’ (ASX:POH) Indian licensee has arranged to sell a diclofenac gel using TPM technology to Novartis India. [ + ]

The federal government has released the draft legislation, to provide the research and development (R&D) tax incentive through quarterly credits, for public comment. [ + ]